Drug Shortage Report for MYLAN-TADALAFIL

Last updated on 2019-08-23 History
Report ID 11788
Drug Identification Number 02410664
Brand name MYLAN-TADALAFIL
Common or Proper name TADALAFIL
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) TADALAFIL
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 4BL
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-12-18
Actual start date 2018-12-18
Estimated end date 2019-08-30
Actual end date 2019-08-22
Shortage status Resolved
Updated date 2019-08-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v29 2019-08-23 French Compare
v28 2019-08-23 English Compare
v27 2019-08-15 French Compare
v26 2019-08-15 English Compare
v25 2019-06-18 French Compare
v24 2019-06-18 English Compare
v23 2019-04-03 French Compare
v22 2019-04-03 English Compare
v21 2019-03-28 French Compare
v20 2019-03-28 English Compare
v19 2019-02-01 French Compare
v18 2019-02-01 English Compare
v17 2018-12-19 French Compare
v16 2018-12-19 English Compare
v15 2018-12-12 French Compare
v14 2018-12-12 English Compare
v13 2018-06-22 English Compare
v12 2018-06-21 French Compare
v11 2018-06-21 English Compare
v10 2018-06-19 French Compare

Showing 1 to 20 of 29